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theoretical and practical implications. The fact that suppres- 
sion can occur by  linked associative recognition argues against 
an anti-idiotype form of suppression in this system. Also, it 
should be possible t o  suppress DTH t o  an antigen A by im- 
munizing with an appropriate antigen B and then reimmu- 
nizing with the  AB conjugate. Preliminary results indicate 
that an established DTH t o  HRBC can be suppressed by first 
immunizing with HCY and then with HCY coupled t o  HRBC. 
This may have practical applications in situations where it 
would be  advantageous t o  suppress a DTH response. 
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U. Koszinowski and Hildegund Ertl Role of early viral surface antigens in cellular immune 
response to vaccinia virus" 
Institute of Hygiene, University of 
Gott i ngen, Gott inge n Infection of mice with the vaccinia virus strain WR, Elstree o r  DIs, a condi- 
tional lethal mutant of vaccinia virus, resulted in the generation of vaccinia 
virus-specific sensitized cytolytic T lymphocytes (CTL). It could be shown 
by cross-reactivity between the three strains and by inhibition experiments 
with specific antisera that early vaccinia surface antigens are sufficient for  
the generation of specific CTL in vivo and for the lysis of infected target cells 
in vitro. 
1. Introduction 
The specific activity of murine cytolytic T lymphocytes (CTL) 
sensitized against viruses [ 1-41, chemically modified cells 
[ 5 ,  61, minor histocompatibility antigens [7] or  H-Y anti- 
gens [ 81 is restricted t o  attacker and target cell homology of 
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Diamidino-2-phenyl-idol EVSA: Early viral surface antigens IF: 
Immunofluorescence LCM: Lymphocytic choriomeningitis LVSA: 
Late viral surface antigens TCID: Tissue culture infective dose VA: 
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the K or D end of the H-2 complex. Killing of modified allo- 
geneic cells is only possible in the  tolerant situation of chi- 
meric mice [9]. CTL activities therefore seem t o  be specific 
for  both H-2 and viral antigens. To obtain further informa- 
tion about possible physiological activities of CTL in the re- 
covery from vaccinia virus infection, the  specificity of the  
sensitizing antigenic structures induced by the virus has t o  
be investigated. Infection with vaccinia virus leads t o  the  de- 
struction of the  infected cell. During virus replication and 
propagation numerous virus-specific antigenic products are 
synthesized in the  cytoplasm and on the surface of the in- 
fected cells. Some of these antigens are structural antigens 
of the  virus while others d o  not  seem t o  be antigenically 
related t o  antigens found on the surface of the  virus particle 
[ lo] .  
Data reported here were obtained after infection of mice 
with different strains of vaccinia virus. These strains differed 
in the expression of viral surface antigens (VSA) on infected 
cells. Early VSA were sufficient for induction of specific CTL 
in vivo and for  lysis of infected cells in-vitro. 
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2. Materials and methods 
2.1. Mice 
C3H mice at the age of 6-1 0 weeks were used throughout, 
purchased from Bomholtgaard, Ry, Denmark. 
2.2.  Viruses and immunization 
Stocks of vaccinia virus strains WR and Elstree were grown 
in VERO (Cercopithecus aethiops) kidney cells. Virus titra- 
tions were performed on  the  same cells. Stock solutions of 
vaccinia virus strain WR and Elstree (Lister strain) contained 
1 x 106 tissue culture infective dose (TCID)50/ml. Strain DIs, a 
vaccinia virus mutant provided by Dr. Ueda, Tokyo, was ob 
tained by serial passages of the  Dairen-I strain of vaccinia 
virus in  one-day-old fertile eggs [ 111. It is a conditional lethal 
mutant, producing n o  clearly recognizable cytopathic effects 
in Hela, FL or primary monkey kidney cell cultures. The 
strain is not virulent for newborn, weaning and adult mice 
and no propagation in mouse tissues or mouse cell lines in 
vitro can be observed. In cells other than those of chick em- 
bryos it fails t o  induce viral DNA and late protein synthesis, 
although early antigens detectable by immunofluorescence 
(IF) and complement fixation are produced [14]. DIs was 
propagated on 12-day-old fertile eggs at  35-36 "C for 2 days. 
Titrations were done on primary chicken fibroblasts [ 121. 
DIs was used in a concentration of 1 x 1 O5 TCIDs0/ml. Puri- 
fication of strain WR was performed according t o  the method 
of Joklik [ 131. Inactivation of vaccinia virus WR was obtained 
by incubation at 56 OC for 1 2 0  min three times interrupted 
by a short sonication procedure. Mice were injected intraperi- 
toneally (i.p.) with 1 ml virus suspension six days before har- 
vesting of spleen cells. 
2.3. Antisera 
Antiserum to strain WR (No. 8):  it  was obtained from rabbits 
immunized with WR strain vaccinia. The animals were injected 
intradermally and after a period of two weeks 3 booster in- 
jections were given with an interval of 1 0  days. Previous to use, 
the antiserum was absorbed on normal mouse cells. This anti- 
serum contains antibodies with cytotoxic activity for  infected 
cells as well as neutralizing antibodies. With this antiserum 
VSA can be demonstrated o n  infected cells by indirect IF. 
After binding to  infected cells, this antibody reacts with cells 
which are active in antibody-dependent cell-mediated cyto- 
lysis (ADCC). 
Antiserum to late vaccinia surface antigens, (anti-L VSA):  
serum No. 8, was extensively absorbed on DIs-infected prim- 
ary chicken fibroblasts. Absorption end point was deter- 
mined when no surface staining activity on  DIs-infected cells 
remained. The absorbed serum stained the surface of cells 
infected with vaccinia strains WR or Elstree by indirect IF. 
The IF by this antibody may not be directed t o  a single 
virus-specific surface antigen, but in this text the antigen(s) 
which is stained after absorption of DIs antigen activity is 
termed as LSVA. 
Antiserum to early vaccinia surface antigens (anti-EVSA) : 
rabbit serum against EVSA was prepared by injection of crude 
soluble early antigens of DIs-infected rabbit kidney cells into 
rabbits. The production of this antibody has been described 
elsewhere in aetail 1 1  21. This antibody has complement fixa- 
tion titers against concentrated soluble antigen. I t  did not 
neutralize vaccinia virus nor did it stain V antigens of vaccinia- 
infected cells. As revealed by IF, this serum contained anti- 
bodies against EVSA. 
Antiserum to structural antigens of the virion (anti-VA): it 
was obtained from rabbits injected with purified inactivated 
vaccinia virus. One ODU [ 151 containing about 6 4  pg viral 
protein was injected intramuscularly, a booster injection of 
the same dose was given 1 4  days later. This antibody had 
neutralizing activity but did not bind t o  the surface of vaccinia 
virus-infected cells. 
All antibodies used had n o  activities against noninfected con- 
trol cells. Neutralizing antibody titers were determined by 
80 % plaque reduction in VERO cell cultures. Indirect I F  
was performed as reported previously [ 151. Demonstration 
of DNA synthesis in vaccinia virus-infected cells was per- 
formed with 4,6-diamidino-2-phenyl-indol (DAPI) [ 161. 
EVSA and LVSA of cells infected with vaccinia virus were 
studied by mixed hemagglutination technique [ 171. 
2.4. Cytolytic antibody assay (CA) 
The method of Kibler and ter Meulen [ 181 was modified for  
L cells as targets and vaccinia strains as infective agents. 
Guinea pig complement was used in a final concentration 
of 20 hemolytic units. Test tubes contained 0.05 ml anti- 
serum, 5 x lo4 "Cr-labeled erythrocytes in 0.05 ml and 
0.1 ml complement. Each assay was run at least in triplicate. 
After 4 h incubation a t  3 7  OC in COz,  supernatant and cells 
were harvested separately and 51Cr release was determined 
according t o  the formula: 
o/o 51 Cr release - 51Cr release %  
(Ab + C) (C alone) 
% Lysis = x 100 
Total incorporated 
(Ab ; c > . . ~ ~ .  
2.5. Cytolysis inhibition assay (CIA) 
Antibodies against cell surface antigens with low cytolytic 
activity were determined by CIA [ 191 modified for the de- 
termination of VSA. As targets, 1 x 104 51Cr-labeled chicken 
red blood cells (CRBC), coated with rabbit anti-chicken ery- 
throcyte antibody, were used. Normal mouse spleen cells 
served as attacker cells in a ratio of A/T of 100: 1. To  this 
reaction mixture were added cold inhibitory third-party cells 
in a ratio of cold cells t o  erythrocyte targets from 20: 1 to  
50: 1. The inhibitory cells were 1) normal 2) virus-infected 
L-929 cells, 3) vaccinia-infected L-929 cells coated with anti- 
vaccinia serum or 4) vaccinia virus-infected L-929 cells + nor- 
mal mouse control serum. Specific cytolytic inhibition was 
calculated using the formula: 
% Specific inhibition = inhibition of CRBC lysis in presence of 
infected inhibitory cells and anti-viral 
antibody minus 
inhibition of CRBC lysis in presence of 
infected inhibitory cells and control serum 
2.6. Cell-mediated cytolysis (CMC) 
Various amounts of lymphocytes from sensitized mice were 
incubated with a constant number (1 x 104) of 5 1  Cr-labeled 
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target cells [4]. The percentage of specific 51Cr release was 
determined using the formula: 
51Cr release by - 51Cr release by 
immune cells by normal cells 
maximal "Cr release 
% Specific lysis = x 100 
The standard deviation (SD) from at least a triplicate assay 
was calculated. The data are given without SD since, under 
test conditions used, the SD of percentage lysis was less than 
5 %. 
3. Results 
Table 2. Anti-viral CMC of CTL from mice. sensitized with different 
vaccinia strains4 
% Specific S 1 C r  
release from L-929 
cells infected withb) 
Sensitization DIs WR Elstree 
1 x 106 TCIDSO WR 45.0 41.8 15.7 
1 x 106 TCIDso Elstree 18.8 27.3 15.1 
1 x 105 T C I D ~ ~  DIS 21.6 14.2 n.t.c) 
Lymphocyte donors were C3H mice 6 days after sensitization. 
Background lysis ranged between 20-25 %; assay time 14 h, ratio 
A/T 100: 1. 
n.t. = not tested. 
3.1. Virus-specific CMC after sensitization of mice with 
different vaccinia strains 
3.2. Inhibition of anti-viral CMC by specific antibodies 
The virus strains tested varied in the expression of  VSA. 
Characteristics of the three strains used are given in Table 1. 
Strain WR, the usual test strain, gave positive results in all 
reactions. Strain DIs did not propagate in L cells, shown by 
negative DAPI staining and the lack of cytopathic effects, 
but there was expression of EVSA. Strain Elstree gave mixed 
hemagglutination results of the single-cell type with anti- 
EVSA. 
Groups of C3H mice were injected i.p. with 1 x lo6 TCIDSO 
vaccinia virus strain WR, 1 x lo6 TCID5 0 strain Elstree or  
1 x lo5 EIDSO strain DIs. Six days later spleen lymphocytes 
were harvested, and the assay was performed with target cells 
infected with each of the three strains. Results (Table 2) show 
that  mice sensitized t o  any of the virus strains kill all infected 
target cells. Also the lymphocytes from mice sensitized to 
DIs are active in vitro. The mice had been injected with a low 
dose of DIs virus, and a virus propagation in the mice did not 
take place and was not necessary for anti-viral sensitization. 
Injection of DIs-infected L-929 cells also led t o  the production 
of killer cells, while after injection of allogeneic infected cells 
there was n o  anti-viral sensitization.* Furthermore there was 
a pronounced killing of DIs-infected cells despite the fact that 
only 60 % expressed VSA by means of indirect IF. Lympho- 
cytes from mice sensitized to DIs were also able t o  lyse tar- 
gets infected with WR and Elstree strain. 
* Koszinowski, U. and Ertl, H., unpublished. 
The data obtained after infection of mice with strain DIs- 
infected cells suggest CTL activities against early VSA. Dif- 
ferent anti-viral sera were prepared to control these results 
in inhibition assays (Table 3). These antibodies were tested 
for inhibitory activities in the anti-viral CMC. Target cells 
were vaccinia virus WR-infected L-929 cells or noninfected 
controls; cytolytic effector T cells were harvested from C3H 
mice sensitized against vaccinia strain WR. Antiserum in 
0.05 ml volume was added to the reaction mixture contain- 
ing 5 x 1 O4 target cells and 5 x 1 O6 effector cells in 0.2 ml  
Table 3. Activities of anti-vaccinia sera 
Serum Indirect cell surface IF CA CIAb) NTC) 
WR DIsa) (%I 
Anti-vaccinia 4- + 1:1024 50-80 1 ~ 3 2  
(No. 8) 
Anti-EVSA 4- + 1:1024 n.t.d) n.t. 
1 5 1 2  n.t. n.t. Anti-LVSA 4- 
1:>4 0-5 1:256 Anti-VA 
- 
- - 
a) Indirect IF was tested with L-929 cells infected with vaccinia 
strains WR and DIs 8 h previously. 
b) Inhibitory activity of cold vaccinia WR-infected L-929 cells 
coated with anti-vaccinia serum No. 8 on antibody-dependent 
cell-mediated lysis of antibody-coated s*Cr-labeled CRBC could 
be demonstrated up to a dilution of 1:1024 of serum No. 8. 
c) Neutralizing activity was tested on VERO cell monolayers. 
d) n.t. = not tested. 
Table 1. CJmracteristics of vaccinia strains 
Indirect hemag- Indirect IF on 
DNA replication Cytopathic effects Titer of virus glutination with surfaces 
Strain in L-929 cellsa) in L-929 cells in testb) ant i-E VS A anti-EVSA anti-LVSA 
(TCIDSO) 
WR Yes Yes 
Elstree Yes Y cs 
DIs No No 
106 pos. +++ +++ 
106 singlecell type (+) ++ 
105 pos. ++ - 
a) Tested with DAPI and by indirect IF with anti-VA. 
b) WR and Elsbree propagated and titrated on VERO cells; DIs propagated on embryonated eggs (chorioalloantois membrane), titrated on 
primary fibroblasts of 6-day chicken embryos. 
682 U. Koszinowskiand H. Ertl Eur. J. Immunol. 1976.6: 679-683 
volume. The results are shown in Table 4. We found signi- 
ficant inhibition of CMC using serum No. 8 and anti-ESVA 
serum. Anti-LSVA serum and serum directed against structur- 
al antigens (anti-VA) had n o  significant inhibitory activities. 
The inhibition test with 1 optical density unit of inactivated 
vaccinia antigen gave negative results, after addition of about 
1.2 x 1 O1 vaccinia virus particles there was no inhibition of 
anti-viral CMC. The virus-specific receptor site of the  cyto- 
lytic T cell does not  seem to recognize antigens of the vaccinia 
virus particle. The data confirm the finding that CTL recog- 
nize early vaccinia surface antigens. 
Table 4. Anti-viral CMC in presence of specific antibodies or 
inactivated virusa) 
Serum Specific lysis 
(%I 
None 
Normal serum 
Anti-vaccinia (No. 8) 
Anti-EVSA 
Ant i-LVSA 
Anti-VA 
2 x 1010 vaccinia particles 
27.4 
24.8 
15.0b) 
17. lb) 
23.7 
25.8 
32.4 
a) Donors of vaccinia-immune spleen cells were C3H mice infected 
6 days previously with vaccinia WR. Target cells were WR-in- 
fected L-929 cells. Ratio A/T 1OO:l. Incubation time 12 h. Back- 
ground lysis less than 25 %. 
b) Significant lower specific 51Cr release (P < 0.05). 
4. Discussion 
Vaccinia virus infection leads to production of several anti- 
gens coded by the virus. It has been supposed earlier 
[ 10, 121 that the EVSA might play an essential role in cellular 
immunity. Taking advantage of a conditional lethal mutant 
strain of vaccinia virus [ 1 11 evidence can now be presented 
that  EVSA induced by vaccinia virus give rise t o  anti-vaccinia 
CTL. Strain DIs infects mouse cells in uitro and in v i vo ,  but 
there is no DNA replication shown by virus titration, indirect 
IF and DNA staining. Injection of DIs-infected cells into mice 
causes a virus-specific CTL response. Cellular immune response 
is therefore directed against EVSA expressed on  these cells. 
Our data give no clear-cut results about the role of LVSA. 
The strain Elstree is only partially defective in production 
of EVSA, which can be shown by mixed hemagglutination 
technique [ 171. The CTL activity of mice after sensitization 
with this strain seems to be lower but does not differ signi- 
ficantly from the response after infection with strain WR 
or  DIs. 
The inhibition experiments (Table 4) outline the significance 
of EVSA in the effector phase of anti-vaccinia CMC. It could 
be shown in earlier experiments that the activity of the anti- 
viral CTL can be inhibited specifically either by  H-2 alloanti- 
sera or by anti-viral sera which has been confirmed recently 
in the CTL activity against 2,4,6-trinitrophenyl-modified 
cells [ 3 ,  15, 201. Experiments to  show inhibition of CMC 
after the addition of alloantibodies often give unreliable re- 
sults. After capping of SD antigens or of VSA, the lysis by 
CTL can more effectively be inhibited by  addition of allo- 
antibody or  anti-viral antibody even during the  test period. 
I t  cannot be ruled out  that  the anti-LSVA serum might also 
have inhibitory activity in higher concentrations. Antibodies 
raised against inactivated virus particles (anti-VA) have only 
neutralizing activities while antibodies reactive against EVSA 
only lyse infected target cells in presence of complement 
and inhibit anti-viral CTL activity. Therefore virus-neutra- 
lizing and CTL inhibitory or lytic properties for infected 
cells can clearly be separated 
Contact with complete virus particles is not necessary for the 
generation of CTL since injection of DIs-infected syngeneic 
cells also leads to effective killer cell production. In parallel, 
the  cytolytic interaction could not  be inhibited by large 
amounts of inactivated vaccinia virus particles. Injection of 
inactivated virus into mice does not  cause CTL production. 
For  the investigation of the  possible biological role of the 
cytolytic activity of T cells, Sensitization and reactivity 
against EVSA seems to be advantageous. EVSA are expressed 
as early as 1 h after infection of cells [ l o ]  while maturation 
of complete infective virus needs several hours. Moreover, re- 
lease of infective viral particles begins very early and does not 
lead at once to destruction of the host cell. Vaccinia virus has 
a tendency to attach t o  cell surfaces and can spread directly 
from cell t o  cell despite specific neutralizing antibody in the 
surrounding medium [21]. Reacting against EVSA, the  CTL 
prevents viral DNA synthesis and in later stages the spreading 
of virus. I t  is tempting to assume that  EVSA, whose role in 
vaccinia replication is unknown, “modify” H-2 antigenic 
structures and in addition give virus specificity of the H-2-re- 
stricted anti-viral CMC. However, experiments performed to 
demonstrate inhibition of viral proliferation by CTL in v i t ro  
have so far been unsuccessful. 
We thank Dr. Y. Ueda, Tokyo for supplying DIs virus and anti-ESVA 
serum and Dr. C. Jungwirth, Wiirzburg for purification of vaccinia 
virus WR. The technical assistence of Ms. K.B. Henderson and Ms. S. 
Siebels is gratefully acknowledged. 
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The xenogeneic effect - 
Evidence for coparticipation of human monocytes and 
T lymphocytes in the restoration of nude mouse in vitro 
response to sheep red blood cells" 
The restorative ability of human peripheral blood lymphocyte fractions on  
nude mouse spleen cell in vitro antibody response t o  SRBC was studied. 
Strongly adherent cells (monocytes) enhanced nude cell response, but not 
t o  the same extent as the optimal number ( l o 6 )  of unfractionated human 
peripheral blood lymphocytes. T-depleted cells lost their ability to  optimally 
restore the response, while T-enriched cells showed a definite restorative abili- 
ty. The recombination of adherent cells with T-enriched cells produced a n  
effect comparable t o  that of unfractionated cells, both in terms of magnitude 
and dose-response curve. These data suggest that both monocytes and T cells 
are necessary for a n  optimal xenogeneic effect in Mishell-Dutton cultures. 
1. Introduction 
The antibody response is modulated by several kinds of solu- 
ble factors. T cells have been shown t o  produce factors which 
enhance B cell response t o  T-dependent antigens, both speci- 
fically [ 1, 21 and nonspecifically [3 ,  41. It is probable that  
both specific and nonspecific factors are simultaneously pro- 
duced by T cells [ 5-71 and may act synergistically in the im- 
mune response [ 51. In addition, activated macrophages pro- 
duce non-antigen-specific factors capable of augmenting the 
in vitro antibody response in a T-depleted system [S-lo]. 
The nature and degree t o  which these factors contribute t o  
the antibody response is not yet fully clear. One of the most 
important findings in the analysis of the mechanisms of action 
of such factors has been the  demonstration that physiological 
T-B cell cooperation cannot be demonstrated across a barrier 
at the major histocompatibility locus [ 1 I ] .  However, nonspeci- 
fic T cell factors are in most cases [ 121 active on nonhistocom- 
patible B cells, and an antigen-specific T cell factor has recent- 
[I 14261 
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ly been shown t o  act across an allogeneic barrier [ 131. Thus, 
the biological significance of the histocompatibility-linked 
restriction t o  cellular cooperation remains t o  be fully deter- 
mined. The study of interactions between xenogeneic cells 
may provide an additional approach t o  this problem. 
The ability of human peripheral blood lymphocytes (PBL) 
t o  produce factors enhancing the in vitro antibody response 
of mouse cells has been demonstrated in two experimental 
situations. Rubin et  al. [ 141 have shown that allogeneic mix- 
tures of human lymphoid cell lines, or tetanus toxoid-stimu- 
lated normal human PBL could produce such an enhancing 
factor for normal mouse spleen cell cultures. On the other 
hand, direct addition of human PBL t o  cultures of T-depleted 
mouse spleen cells has been shown to restore their antibody 
response toward the T-dependent antigen sheep red blood 
cells (SRBC) [9, 15, 161 using three different sources of T- 
depleted cells: an t i -8  + C-treated cells [9], cells from thy- 
mectomized, irradiated and bone marrow-reconstituted mice 
[ 151 and cells from nude mice [ 161. However, the nature of 
the human peripheral%lood cell responsible for  this effect 
is controversial. Wood has provided evidence that the  re- 
storative capacity of human cells was restricted t o  mono- 
cytic adherent cells and has shown that short-term mono- 
cyte culture supernatants had an enhancing effect [9, 161. 
Alternatively, Farrar has demonstrated that  adherent cell 
depletion rather increased the restorative ability of human 
cells [ 151 and recently provided evidence that stimulation 
of human cells with T cell mitogens led t o  the production 
of soluble enhancing factors [ 171. 
This work has been designed t o  investigate the respective 
role of monocytes and T cells in this xenogeneic effect. The 
effect of fractionated human peripheral blood cell popula- 
